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Abstract: Hepatitis C virus (HCV) infection is now considered a pandemic. It has emerged as the most important 
cause of chronic liver disease world wide and an important cause of acute hepatitis and jaundice in pregnancy and its 
attendant complications. The disease prevalence was determined among 300 women of childbearing age attending 
Vom Christian Hospital, Plateau State, Nigeria. A structured questionnaire was administered to each subject to 
obtain data on socio-demographic and risk factors that may be associated with their predisposition to the infection. 
One step HCV immunochromatographic test strip was used for the screening. 27 (9.0%) subjects were seropositive. 
Women in the age group 26-30 years had the highest seroprevalence of 9.3%. There was no significant association 
between age and HCV seroprevalence (x2 = 8.403, df = 5, P = 0.20). Seropositivity in some subjects was linked to a 
number of risk factors which included scarification and multiple sex partnership. The results obtained indicate the 
presence of HCV in the study area and the need for effective awareness to educate the public on preventive 
measures against contraction and transmission of the disease. 
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1. Introduction 
 Hepatitis C is an infectious disease affecting 
the liver. It is caused by Hepatitis C virus (HCV) 
Ryan & Ray,2004. The infection was referred to as a 
parenterally transmitted “non-A, non-B hepatitis” until 
identification of the causative agent in 1989. The 
discovery and characterization of HCV led to the 
understanding of its primary role in post transfusion 
hepatitis and its tendency to induce persistent 
infection (Choo,et al 1989 & Sharara et al,1996). It is 
estimated that there are more than 170 million chronic 
HCV carriers worldwide who are at risk of developing 
liver cirrhosis, liver cancer, or both Brooks et al,2007. 
It is thought that HCV infection is now a 
pandemic, with most of those infected in developing 
countries, including sub-Saharan Africa. It has 
emerged as the most important cause of chronic liver 
disease world wide and an important cause of acute 
hepatitis and jaundice in pregnancy and its attendant 
complications, Ojule et al, 2008. 
 Results from several studies have shown 
variation in seroprevalence of HCV in childbearing 
women from 0.6% in Japan Uehara et al, 1993 to 
4.5% in the United State (US) Reinus et al,1992. The 
principal risk factors were history of intravenous drug 
use and exposure to blood and blood products Ward et 
al, 2000. Available data out of Africa has shown a low 
prevalence (0.6%) of HCV infection among child 
bearing women in Sudan et al, 2007 with Egypt 
having the highest prevalence (19%)10. Recent studies 
in Nigeria indicated that the HCV prevalence among 
pregnant women ranged from 4.3% to 9.2% (Ojule et 
al, 2008 & Paul et al 2007). 
 HCV is spread primarily by direct contact 
with human blood,Villano et al 1999. HCV antibody 
screening of blood and blood products introduced 
during the early 1990s has minimised this mode of 
HCV acquisition, leaving vertical transmission from 
infected mothers as the predominant mode of infection 
in children. It is worthy of note that, though HCV was 
identified in 1989, no effective screening test for the 
infection was available until 1992. Thus all women 
who had caesarean section, vaginal birth or other 
gynaecological procedures which required blood 
transfusion prior to 1992 were at risk for hepatitis C. 
Vertical transmission of HCV may occur at 
conception, in utero, perinatally, or during lactation. 
Its mechanisms, including timing, remain largely 
unknown, Hadzic 2001. The dominant route for 
acquisition of HCV infection in children in the 
developed countries is maternal-infant transmission 
with an estimated transmission rate of 5% Resti et al 
1998. 
No vaccine is currently available to prevent 
hepatitis C and treatment for chronic hepatitis C is too 
costly for most persons in developing countries. Thus 
from the global perspective, the greatest impact on 
hepatitis C disease burden will likely be achieved by 
focusing efforts on reducing the risk of HCV 
transmission from nosocomial exposure (e.g. blood 
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transfusions, unsafe injection practices) and high risk 
behaviours (e.g. injection drug use) WHO,1999. 
 Given that childbearing women are at high 
risk of acquiring and transmitting HCV infection 
(especially to their unborn foetus), there is need to 
identify HCV carriers among women in the study 
area. This study therefore is aimed at the detection of 
subjects with HCV infection, increasing awareness 
about the disease and aiding health care providers in 
the management of infected individual. It is also 
aimed at preventing emanating complications of the 
disease and to reduce its attendant socio-economic 
burden in the study area assuming its presence is 
confirmed.  
 
2. Materials and methods  
Study area: This study was hospital based and 
sampling was carried out at Vom Christian Hospital, 
Vom in Plateau State. Due ethical clearance was 
sought and granted for the study. 
 
Study population: Three-hundred (300) blood 
samples from women of childbearing age attending 
Vom Christian Hospital. Informed consent was 
obtained from every participant before a structured 
questionnaire was administered to each. The 
questionnaire was designed to obtain their socio-
demographic predispositions and risk factors that 
expose individuals to HCV infection. These can be 
seen in table 1 of results presented. 
 
Collection and processing of blood samples: 5ml of 
blood sample was collected by venepuncture from the 
antecubital fosa of the arm after disinfection with 70% 
alcohol. Samples were placed in labelled sterile test 
tubes and allowed to clot. The sera was separated out 
into pre-labelled cryovials and transported in a cold 
box to Virology laboratory of the Federal College of 
Veterinary and Medical Laboratory Technology 
(FCVMLT) Vom, Plateau State. These were stored at 
-20oC until tested.Screening for HCV 
antibodies:Detection of HCV antibodies was carried 
out using commercially available One Step Rapid Test 
HCV kits (PISTIS Diagnostic Ltd; USA), a rapid 
chromatographic immunoassay for the qualitative 
detection of antibody to HCV in serum or plasma. 
Manufacturer’s instructions were strictly adhered to.  
 
Test procedure: Sera samples were removed from the 
-20oC freezer and allowed to thaw and attain room 
temperature. Each strip with arrow pointing 
downwards was removed from the pouch and 
immersed vertically into a sample. The strip was 
removed after 10 seconds and results read within 10 – 
20 minutes.  
Statistical analysis 
Data obtained were analysed using SPSS computer 
software. 
3. Results:27 (9.0%) of the 300 samples screened 
were seropositive for HCV as seen in Table 1. Women 
of age groups 21-25 and 26-30 years showed HCV-
seropositivity of 8 (8.2%; 9.3% respectively). This 
was the highest value of prevalence recorded in age 
groups as seen in table 2. Statistically, there exists no 
significant difference in the association between age 
and seroprevalence of HCV (P = 0.20). 
 The seroprevalence of HCV with respect to 
demographics showed that they really did not play a 
major role in the contraction of the disease as seen in 
table 2. Married women recorded 9.2% seropositivity. 
Women with low educational standing showed 12.5% 
seropositivity. Unemployed women had a prevalnece 
of 10.7%. Considering gravidity, a 13.8% value was 
recorded. HCV seroprevalence with respect to 
predisposing risk factors showed that 9 (24.3%) out of 
37 women with body marks or tattoos were 
seropositive for HCV. 2 (25%) of the 8 women who 
practised multiple sex partnership were also 
seropositive. All the women who had history of blood 
transfusion and surgical operation were seronegative 
as seen in table 2. 
 
 
Table 1: Prevalence of HCV antibodies  
Age group (years) Nos. Screened (%)  Nos. Positive (%) Nos. Negative (%) 
16 – 20 65 (21.7%) 5 (7.7%) 60 (92.3%) 
21 – 25 97 (32.3%) 8 (8.2%) 89 (91.8%) 
26 – 30 86 (28.7%) 8 (9.3%) 78 (90.7%) 
31 – 35 29 (9.7%) 2 (6.9%) 27 (93.1%) 
36 – 40 15 (5.0%) 1 (6.7%) 14 (93.3%) 
41 – 45 8 (2.6%) 3 (37.5%) 5 (62.5%) 
Total 300(100.0%) 27 (9.0%) 273 (91.0%) 
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Table 2: Prevalence of HCV antibodies correlated with demographic/ risk factors 
Variable Nos. Screened (%) Nos. Positive (%) P VALUE 
Demographics    
Age   0.20 
16 – 20 65 (21.7%) 5 (7.7%)  
21 – 25 97 (32.3%) 8 (8.2%)  
26 – 30 86 (28.7%) 8 (9.3%)  
31 – 35 29 (9.7%) 2 (6.9%)  
36 – 40 15 (5.0%) 1 (6.7%)  
41 – 45 8 (2.6%) 3 (37.5%)  
    
Marital Status   0.8 
Married 283 (94.4)% 26 (9.2%)  
Single 16 (5.3%) 1 (6.3%)  
Divorced 1 (0.3%) 0 (0.0%)  
    
Educational Status   0.20 
Primary 182 (60.7%) 17 (9.3%)  
Secondary 72 (24.0%) 9 (12.5%)  
Tertiary 20 (6.7%) 0 (0.0%)  
Non-formal 26 (8.6%) 1 (3.8%)  
    
Occupational Status   0.20 
Employed 14 (4.7%) 1 (7.1%)  
Unemployed 214 (71.3%) 23 (10.7%)  
Self-employed 72 (24.0%) 3 (4.2%)  
    
Gravidity   0.20 
Yes 242 (80.7%) 19 (7.9%)  
No 58 (19.3%) 8 (13.8%)  
    
Risk factors    
Blood transfusion    
Yes 8 (2.7%) 0 (0.0%)  
No 292 (97.3%)   
    
Surgical operation    
Yes 18 (6.0%) 0 (0.0%)  
No 282 (94.0%)   
    
Body marking/tattooing    
Yes 37 (12.3%) 9 (24.3%)  
No 263 (87.7%)   
    
Multiple sex partnership    
Yes 8 (2.7%) 2(25.0)  
No 292 (97.3%)   
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4. Discussion 
Our finding of 9.0% prevalence has 
important health implications for the large number 
of childbearing women      and their families who 
reside in our location of study. This is because most 
of the infected women were ignorant of HCV 
infection neither are they aware of their infection 
status since they showed no symptoms and tend to 
assume normal lives.  
This implies that there is considerable 
potential for the transmission of HCV infection to 
people around them especially to foetuses in the 
case of the 19 (7.9%) HCV seropositive pregnant 
women our finding is similar to the report from 
South Western Nigeria which reported a prevalence 
of 9.2% among similar subjects in a tertiary 
hospital in Ibadan11.  
The seroprevalence of HCV in this study is 
high when compared to that described previously 
among similar subjects in some African countries 
such as: Sudan (0.6%)9, Tanzania (1.0%) Msuya et 
al 2006 and Burkina Faso (3.3%) Simpore,2005 as 
well as in some developed countries such as 
Scotland (0.4%) and Brazil (1.5%) Lima et al,2000 
& Hutchinson et al,2004. On the other hand, it 
appears low compared that previously reported in 
Malawi (16.5%)Ahmed,1998 and Egypt (19%) 
Kassem et al 2000. These differences observed may 
be attributed to degree of exposure to risk factors in 
the study populations as we found out that 
demographic variables considered had no statistical 
significance with HCV seropositivity. 
 With regards to age groups screened, the 
highest prevalence of 37.5% was recorded among 
women of age group 41 – 45 years. This result 
agrees with the findings in previous work which 
showed increase in HCV seroprevalence with 
increase in age, Hutchinson et al 2004. However, 
statistical analysis showed no significant 
association between age and HCV seropositivity 
(P=0.20) for our study only that those aged 21-30 
years seemed to be more infected.  
       The fact that married women showed a 
higher seropositivity may point a finger to their 
route of infection suggesting that sexual exposure 
may facilitate the spread of HCV and they were 
told to advise their spouses to undergo HCV 
screening. Education and employment wise, we 
found out that women with low levels of education 
and the unemployed showed higher seroprevalence 
indicating that their low socio-economic and 
educational status may have contributed to their 
status, though this association may not be 
concrete,(El-Sheikh et al,2007).This we attributed 
to poor enlightenment which is usually associated 
with poor educational background. 
        Assessment of risk factors among 
seropositive women revealed that 9 (24.3%) of the 
37 women who had scarification such as body 
marks and tattoos were seropositive. Similarly, 8 
women were involved in multiple sex partnership, 
but only 2 (25.0%) were seropositive. These 
suggest that these risk factors may be important in 
the spread of HCV infection among childbearing 
women. Worthy of note is the fact that a HCV sero-
negative result does not imply immunity against 
future exposure to the virus. Therefore HCV 
screening on routine basis should be strongly 
considered for all childbearing women in this 
community since the disease presence has been 
established.    
      
Conclusion: The result of this study indicates that 
HCV is endemic in the study area. Its prevalence 
among women of childbearing age (9.0%) was 
found to be as high as that obtained in the South 
Western part of the country and higher than rates 
recorded in some other African countries. Infected 
women can transmit the infection to their family 
members. Due to the high cost of treatment of HCV 
infection and the unavailability of a vaccine against 
HCV, efforts should be focused on preventive 
aspects like regular screening.  
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